BIOMAT Database Logo BIOMAT Database Logo

Combined treatment with furosemide and reserpine in cases of hypertension. 1973

V H Yajnik, and S V Solanki

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V H Yajnik, and S V Solanki
[Furosemide-reserpine association in the treatment of arterial hypertension (37 cases)].
March 1970, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
V H Yajnik, and S V Solanki
[Saluretic treatment of hypertension. Experiences with furosemide-reserpine (Nortensin)].
June 1971, Munchener medizinische Wochenschrift (1950),
V H Yajnik, and S V Solanki
[The hypotensive effect of reserpine, furosemide and reserpine in combination with furosemide in experimental renal hypertension in rats].
May 1966, Arzneimittel-Forschung,
V H Yajnik, and S V Solanki
[Treatment of hypertension with hygroton and hygroton combined with reserpine].
January 1973, Kardiologiia,
V H Yajnik, and S V Solanki
[Treatment of arterial hypertension with reserpine; report of cases].
May 1954, Revista clinica espanola,
V H Yajnik, and S V Solanki
[Use of the association of furosemide and reserpine in the treatment of arterial hypertension].
March 1970, Minerva medica,
V H Yajnik, and S V Solanki
[Treatment of severe essential arterial hypertension with combined reserpine and hydrochlorothiazide].
February 1960, Il Policlinico. Sezione pratica,
V H Yajnik, and S V Solanki
[Combined treatment of patients with hypertension with reserpine and ganglion-blocking agents].
August 1958, Klinicheskaia meditsina,
V H Yajnik, and S V Solanki
[Combined treatment of arterial hypertension; 1-hydrazinophthalazine + reserpine].
April 1957, Prensa medica argentina,
V H Yajnik, and S V Solanki
POLYTHIAZIDE AND RESERPINE COMBINED IN THE OFFICE TREATMENT OF HYPERTENSION.
April 1964, Angiology,
Copied contents to your clipboard!